Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Lilly Reduces the Price of Zepbound
Published 5 months, 2 weeks ago
Description
In today’s Pharmaceutical Executive Daily, Eli Lilly reduces the price of Zepbound single-dose vials for self-pay patients, a new report claims the FDA is planning changes to its vaccine approval process following assertions of COVID vaccine–related deaths, and Korea and Australia reorient their pharma launch strategies toward broader regional market opportunities.